|Publication number||US20050206039 A1|
|Application number||US 11/131,831|
|Publication date||Sep 22, 2005|
|Filing date||May 18, 2005|
|Priority date||Aug 18, 1999|
|Also published as||US6936072, US20030125807|
|Publication number||11131831, 131831, US 2005/0206039 A1, US 2005/206039 A1, US 20050206039 A1, US 20050206039A1, US 2005206039 A1, US 2005206039A1, US-A1-20050206039, US-A1-2005206039, US2005/0206039A1, US2005/206039A1, US20050206039 A1, US20050206039A1, US2005206039 A1, US2005206039A1|
|Inventors||Gregory Lambrecht, Sean Kavanaugh, Scott Stonebrook|
|Original Assignee||Gregory Lambrecht, Sean Kavanaugh, Scott Stonebrook|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (99), Referenced by (13), Classifications (101)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a divisional of U.S. application Ser. No. 10/194,428 filed Jul. 10, 2002, which claims benefit to U.S. Provisional Application No. 60/311,559 filed Aug. 10, 2001 and U.S. Provisional Application No. 60/304,545 filed Jul. 10, 2001, and which is a continuation-in-part of co-pending U.S. application Ser. No. 09/696,636 filed Oct. 25, 2001, which is a continuation-in-part of co-pending U.S. application Ser. No. 09/642,450 filed Aug. 18, 2000, which is a continuation-in-part of co-pending U.S. application Ser. No. 09/608,797 filed Jun. 30, 2000, which claims benefit to U.S. Provisional Application No. 60/149,490 filed Aug. 18, 1999, U.S. Provisional Application No. 60/161,085 filed Oct. 25, 1999 and U.S. Provisional Application No. 60/172,996 filed Dec. 21, 1999, the entire teachings of these applications being incorporated herein by reference.
1. Field of the Invention
The present invention relates generally to intervertebral disc devices suitable for delivery into a body to treat injured discs or to improve the function of non-injured discs.
Methods of encapsulating a new intervertebral prosthesis are not known in the art. The most relevant prior art can be found in references concerning the encapsulation of stents and grafts in flexible biocompatible materials. However, these references are limited to teaching the coating of certain cylindrical structures with a single or double-sided coating of expanded polytetrafluoroethylene. These teachings do not address some or all of the requirements of a new intervertebral disc device which may be semicircular in cross-section, collapsible, fatigue resistant, biocompatible, and suitable for the dynamic disc environment.
Fluoropolymer tubings and other extruded or expanded polymer products are well known in the art and can provide an excellent material for encapsulation. Expanded polytetrafluoroethylene (ePTFE) is made by expanding polytetrafluoroethylene (PTFE) tubing or sheet material under controlled conditions during the manufacturing process. This process alters the physical properties of the material by creating microscopic pores in the structure of the material. The resulting material is imparted with unique physical properties that make it ideal for use in medical devices, electronic insulators, high performance filters, and a host of other applications. Material made from ePTFE differs from regular PTFE in that the material is microporous, soft, very flexible, has a lower dielectric constant, increased linear strength, and improved biocompatibility.
The structure of ePTFE is unique in that the material is made up of a number of solid nodes inter-connected by a matrix of thin fibrils. The gaps, or pores, between the fibrils are what allows the material to excel in applications requiring cellular ingrowth. ePTFE is also utilized for its endothelization and thrombogenic properties. Both ePTFE and PTFE resin have long been utilized for implantable medical devices due to their inertness and biocompatibility. The amount of expansion in ePTFE is usually referred to as internodal distance (IND). IND is a measure of the average distance between the material's nodes. ePTFE is commonly available from manufacturers in IND sizes ranging from 5μ to over 200μ. IND plays a role in the softness, flexibility, and degree of potential ingrowth that the material exhibits. Some commercial suppliers of ePTFE sinter the outside of the material after the expansion process in order to make it more durable and smooth.
Other useful PTFE based materials known in the art are PTFE resin aqueous dispersions or “aqueous PTFE” and heat shrinkable PTFE. Aqueous PTFE is commonly comprised of milky white dispersions of PTFE particles in water stabilized by wetting agents. Its composition is usually 30 to 60 percent PTFE particles and the remainder is comprised of water and a nonionic surfactant. Objects can be dip-coated with repeated passes into aqueous PTFE until the final desired thickness is obtained. The water can then be removed and the other ingredients deactivated. The melting temperature of these resins are around 325° Celsius. The dried resin particles can be coalesced by heat into a continuous coating or the substrate can remain coated, or impregnated, with unmelted particles. Both glass fabric and synthetic substrates can be processed.
Heat shrinkable PTFE tubing is well known in the art and provides a method for the application of a tight, protective covering to items that will be subjected to the extremes of heat, corrosion, shock, moisture, and other critical environmental conditions. Shrinkable PTFE tubing requires around 340° Celsius to recover. Upon reaching approximately 330° the PTFE goes into the “gel” state (amorphous from crystalline). PTFE begins to shrink at 340° and completes its recovery during the cooling cycle.
This disclosure utilizes particular orthopedic references, nomenclature, and conventions. Accordingly, several background figures and descriptions are included to aid in the understanding of the environment under which specific embodiments of the invention may be used.
The invention relates generally to methods of manufacture of intervertebral disc devices suitable for delivery into a body to treat injured or poorly functioning discs or to reinforce healthily discs.
In one or more of the several embodiments, the present invention provides for an intervertebral disc prosthesis that is biocompatible, collapsible, concave shaped, and sized to fit within the area defined by the superior and inferior end plates and outermost lamella of the anulus fibrosus of a functional spinal unit.
It is further objective of one or more of several embodiments of this invention to provide a device useful in shielding the nerves of the anulus and spinal cord from pressure and or chemicals within the disc.
It is a further objective of one or more of various embodiments to provide a device that provides support to a weakened or healthy anulus in an intervertebral disc.
It is a further object in one or more of the several embodiments to provide a method for the manufacture of one or more of the several embodiments of the invention.
It is a further object to provide in one or more of the several embodiments an encapsulating covering that is permanently retained on an intervertebral barrier device and substantially isolates it from bodily tissue.
It is a further objective of one or more of various embodiments to provide a method of encapsulating an intervertebral prosthesis in a biocompatible material that does not interfere with the deformation and flexibility of the barrier frame.
It is another object of several embodiments of the invention to provide a method of making an intervertebral disc implant by providing a barrier frame having first and second sides, positioning a first membrane adjacent the first side and a second membrane adjacent the second side, applying force so that the first membrane contacts the second membrane at one or more points and heating the first and second membrane to form bonds at one or more of those points. The first membrane may be attached to the second membrane. In one embodiment, the first membrane and second membrane may be opposing sides of an envelope. In a preferred embodiment, the first and/or second membrane is an ePTFE membrane. In another embodiment, a portion of the membrane is positioned beyond the frame or its periphery.
It is yet another object of the current invention to provide a method for making an intervertebral prosthesis by placing a first encapsulating material over a mandrel, placing a device frame on the first encapsulating material, placing a second encapsulating material on top of the device frame, placing a mandrel cover on top of the second encapsulating material and applying force so that the edges of the first and second encapsulating material form contact points with each other around the device frame and heating the mandrel and/or cover until the first and second encapsulating material bond to each other at the contact points, thereby encapsulating the frame.
It is yet another object of the current invention to provide a method for making an intervertebral prosthesis by placing a first biocompatible encapsulating material over a heatable mold with a curved face, the material being sized to extend from about 0.1 mm to about 0.5 mm beyond the edges of a barrier frame. The barrier frame, which is dimensioned to span beyond the distance defined by the maximun distance between an inferior and superior endplate of a normal intervertebral disc and to extend circumferentially along the lateral and posterior surfaces of an anulus, the barrier having a semi-circular cross-section and comprised of nickel titanium alloy, is placed on the first encapsulating material. A second encapsulating material, designed to extend from about 0.1 mm to about 5 mm beyond the edges of the barrier frame, is placed on top of the device frame. A mold cover with a concave interior corresponding to face of the mold on top of the second encapsulating material is placed on top of the device frame. Force is then applied such that the edges of the first and second encapsulating material form one or more contact points with each other around the barrier frame. The base and/or the cover and/or the frame sandwiched between the first and the second encapsulating material is heated until the first and second encapsulating material bond to each other at said one or more contact points.
It is a further object of various embodiments of the present invention to provide a method for making an intervertebral prosthesis by placing a first biocompatible encapsulating material over a heatable mold with a curved face, where the curved face has a first axis and a second axis which are perpendicular to one another. The first axis is a longitudinal axis which has a first radius of curvature and the second axis is a transverse axis which has a second radius of curvature. The first radius of curvature has a range of about 0.1 cm to about 4 cm and the second radius of curvature has a range of about 2.0 cm to about 7.0 cm. Alternatively, the device can be ‘U’ shaped in the transverse orientation and preferably has lateral legs in the range of about 0.1 cm to about 2.0 cm that protrude perpendicularly through a gradual curve with an inner diameter in the range of about 0.2 cm to about 1.5 cm.
The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of preferred embodiments of the invention as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.
The environment in which various embodiments of the present invention find greatest utility is within a human intervertebral disc that has a weakened or compromised anulus.
Intervertebral disc 315 is comprised of the outer anulus 310 which normally surrounds and constrains the nucleus 320 to be wholly within the borders of the intervertebral disc space. Axis M extends between the anterior (A) and posterior (P) of the functional spine unit. The vertebrae also include facet joints 360 and the superior 390 and inferior 390′ pedicle that form the neural foramen 395.
In several of embodiments herein, the present invention provides a device for sealing or reinforcing defects in tissue walls separating two anatomic regions of the body and to methods of making such device. Alternatively, one or more of the several embodiments of the device may be used to provide support to tissue walls that do not exhibit holes but are nonetheless weakened and can benefit from an implanted support structure. Also, prosthetic devices and method of their manufacture are disclosed which provide the closure or support of a defect in the anulus of the human intervertebral disc, preventing the egress of material from within the disc and/or distributing pressure within the disc space across an inner wall surface of the disc.
Closure of the defect and/or support of the weakened sector comprising the defect can be achieved by placing a membrane or barrier device on an interior aspect of the defect. In the case of the intervertebral disc, the device 120 is positioned either on the interior aspect of the anulus proximate to the nucleus or between layers of the AF. The device 120 may be inserted in the desired location after dissecting a space between the anulus and nucleus. Alternatively, a portion of the nucleus and/or anulus may be resected to create adequate space. Ideally, the device 120 is inserted through a defect in the anular surface or through a minimally invasive iatrogenic hole 300. Such a hole is shown in
The geometries of the support frame 53 shown in
This embodiment employs a multitude of fingers 162 to aid in holding the membrane against the superior and inferior vertebral endplates. The distance between the superior-most point of the superior finger and the inferior-most point on the inferior finger is the frame height 172. This height 172 is preferably greater than the disc height at the inner surface of the posterior anulus. The greater height 172 of the frame 53 allows the fingers 162 to deflect along the superior and inferior vertebral endplates, enhancing the seal of the device 120 against egress of material from within the disc 15.
The spacing between the fingers 162 along the frame length 170 can be tailored to provide a desired stiffness of the frame 53. Greater spacing between any two neighboring fingers 162 can further be employed to insure that the fingers 162 do not touch if the frame 53 is required to take a bend along its length. The central strut 164 can connect the fingers and dissecting ends and preferably lies along the inner surface of the anulus 10 when seated within the disc 15. Various embodiments may employ struts 164 of greater or lesser heights and thicknesses to vary the stiffness of the overall frame 53 along its length 170 and height 172.
In an alternative embodiment, the device can be ‘U’ shaped in the transverse orientation and preferably has lateral legs in the range of about 0.1 cm to about 2.0 cm, preferably in the range of about 0.5 cm to about 1.3 cm, that protrude perpendicularly through a gradual curve with an inner diameter in the range of about 0.2 cm to about 1.5 cm.
The encapsulating membrane or material 51 of the device 120 may be a relatively soft, smooth, and flexible biocompatible material so that the device 120 does not injure the intra anular walls or superior and inferior endplates. Bio-compatality and inertness are also important so that there is minimal physiological reaction to the device 120. The material(s) comprising the encapsulating material 51 can be impermeable to liquid transfer such that its surface does not permit travel of disc tissue through its surface and outside the disc. Accordingly, the preferred embodiment is made of ePTFE, which exhibits these properties. ePTFE is also strong and resilient enough to withstand the high pressure and dynamic environment found in the intervertebral disc and aids in the devices ability to seal defects and shield nerves in the anulus. Preferably, the internodal distance of the ePTFE, i.e., the average distance between the material's nodes, ranges from 0.μ to over 200μ. As will be further discussed, the encapsulating membrane 51 can fully or partially encapsulate the frame 53 or merely form a portion of a single side of the frame 53.
Though the preferred embodiment of the device 120 utilizes ePTFE for the encapsulating material 51 other suitable biocompatible materials may be used. For example, the membrane may alternatively comprise biologic materials such as keratin, collagen, bio-engineered anulus fibrosus, protein polymers or the like. Other suitable synthetic materials include polyamides, polyimides, silicones, polyurethane, natural rubber, latex and other fluoropolymers such as perfluoroalkoxy (PFAs) and fluorinated ethylene-propylene (FEP). These materials can be affixed to the barrier frame through compression molding, solvent bonding, injection molding, or through in situ polymerization.
In one embodiment of the invention, the encapsulating material or membrane 51 can be fixed to the frame 53 by sutures. The frame 53 may simply be encapsulated in ePTFE material by suturing two pieces of material around the periphery of the frame 53. Also, to minimize the amount of stitches, a single folded piece of material or a tube may be used. This method provides a very durable attachment between the two pieces of material and yet permits the device to flex evenly. Suturing the encapsulating material 51 to the frame 53 can also permit the frame 53 to move or flex relatively unimpeded by the encapsulating material 51. Suturing is also advantageous because it is strong, reliable, finely detailed, and will not harm the disc. In addition to suturing along the periphery of the frame 53, the fingers 162 and internal geometry of the frame may be secured to the encapsulating material by suturing.
Ultrasonic welding may also be used as above to bond the edges of the ePTFE to each other around the periphery of the barrier frame 53. Because of the intense heat delivered by this method, the mechanical properties of the ePTFE may be different at the weld. This can be reduced by selectively welding the encapsulating material at measured points spanning the periphery of the barrier frame including between the fingers 162 and between other voids in the geometry.
In a preferred method of manufacturing the device 120, the frame 53 is encapsulated in ePTFE by first making a sandwich-like arrangement 300 of the frame 53 and a first 54 and second encapsulating material 55. Each of the encapsulating material 54 and 55 is comprised of a thin sheet of ePTFE that is patterned to extend around from about 0.004 inches to about 0.25 inches beyond the periphery of the frame. The thickness of the ePTFE may be between about 0.001 inches to about 0.25 inches and preferably in the range of about 0.005 inches to about 0.025 inches. The IND of each encapsulating material may be in the range of about 5μ to about 200μ with the higher value being more suited to encouraging tissue ingrowth but exhibiting less strength. The IND of each encapsulating material may be different to effect different mechanical properties on either side of the device, mechanical bonding, and fixation. The ePTFE material should preferably be of an unprocessed extrudate variety that has not been subjected to further surface treatments such as sintering and exhibits uniform physical and chemical properties throughout.
Besides exhibiting superior elasticity, strength, and biocompatibility, the material chosen for the barrier frame 53 will preferably be able to withstand the temperatures and exposure times required to monolithically encapsultate it in the encapsulating material 51. In this preferred embodiment, a nickel titanium alloy is chosen.
This method can alternatively be practiced using a tube or folded sheet of ePTFE so that fewer edges need form a bond to effectively encapsulate the frame 53. Using a folded sheet encapsulating material 51 can also be used to create a partially covered frame 53. Alternatively, using a tube is particularly advantageous in forming the arrangement 300 since the step of applying the second encapsulating material 55 is not necessary. The frame 53 is simply inserted in the hollow encapsulating material 51 and then heated in the covered mandrel.
Another method of making the device 120 comprises the adhesion of the first encapsulating material 54 to the second encapsulating material 55 using aqueous PTFE. Here a sandwich of first encapsulating material/aqueous PTFE/barrier frame/aqueous PTFE/second encapsulating material is made and then heated to the melting point of the aqueous PTFE, around 325°, which is less than the sintering temperature of the encapsulating material. In this way, the water and wetting agents are burned off and the PTFE particles melt and mechanically bond to the surfaces of the first and second encapsulating material 51.
Aqueous PTFE or other adhesion material may be used to encapsulate the frame 53 within a tube, folded single sheet, or between two sheets of the encapsulating material 51. Also, selected portions of the encapsulating material 51 can be coated with the adhesion material depending on the degree and location of the bonding one desires. For example, a single sheet encapsulating material 51 on a either side of the frame 53 may be attached with the aqueous PTFE by depositing it along either or both sides of the frame 53 allowing it to contact the encapsulating material through and around the frame 53 and heating it until mechanical bonds form. Other adhesion material may also be used to bond, either chemically or mechanically, the encapsulating material 51 to itself or the frame 53. Examples of adhesion material include, but are not limited to, common medical adhesives like cyanoacrylate, light curing adhesives, urethane, epoxy, and silicone. Further examples include polyamides, polyimides, silicones, polyurethane, natural rubber, latex and other fluoropolymers such PFAs and FEPs.
Heat shrinking PTFE wrap or tubing around the barrier frame 53 is yet another way to provide a biocompatible and resilient encapsulation. PTFE begins to shrink around 340° Celsius and completes its recovery during the cooling cycle. In one method, the barrier frame 53 can be preheated to around 340° Celsius and a slightly larger tube may be placed over it whereupon the tube shrinks in place upon contact and when cooled provides a smooth coverage leaving only two small uncovered spots at the tails of the barrier 53. These uncovered spots do not affect the devices ability to retain intervertebral disc material, pressure, or height. Using the methods described above, these ends may also be sutured or welded. Alternatively, an assembly of the barrier frame 53 placed within a slightly larger tube may be positioned on a mandrel 310 with a hemi circular face and covered with a mandrel cover 320 and then heated to around 340° Celsius until the PTFE shrink fits around barrier frame 53.
As disclosed above, partial encapsulation or covering of the frame 53 may be accomplished with these methods. For example, an encapsulating material 51 comprised of ePTFE disposed around the fingers 162 and face of the device 120 but leaving the center of the frame 53 exposed may be advantageous for delivery and placement of the device. By leaving a portion of the frame 53 uncovered, a solid contact point is provided that can be used to couple the device 120 to a delivery instrument. Alternatively, the encapsulating material 51 can be designed to have a channel within itself or covering a channel in the frame 53 that accepts a guide or probe from the delivery instrument.
An alternative method is comprised of applying an extremely thin, highly expanded PTFE film around the frame 53. By wrapping the film transversely around the long axis of the frame radial strength can be added to the underlying longitudinal strength of the PTFE tube. The radially wrapped tube can then be placed on the mandrel face 310 and compressed and heated to 350-390° Celsius in conjunction with the mandrel cover. The heating process will allow the film to shrink and bond to the underlying PTFE substrate and encapsulating the frame 53. The additional film will provide radial strength and minimize any potential for protrusion of the frame through the PTFE. In addition, while the film wrapping is being performed a template can be placed on the convex side of the PTFE tube. Over-wrapping of this tube will allow for creation of a pocket on the convex side of the frame 53. This pocket in conjunction with the windows left in the tube covering would allow for attachment of a delivery instrument to the convex side of the frame. An important manufacturing consideration of this application method is the need for such high temperatures for sufficient bonding of the PTFE film and its deleterious effects on the underlying metallic substrate. Using an FEP/PTFE laminated film with corresponding lower bonding temperatures of 300-320° Celsius can reduce this effect.
Subsequent to the application of pressure to the first encapsulating material and/or semicircular frame and/or second encapsulating material assembly and sintering the same to mechanically bond the ePTFE, the mandrel cover is removed and the device is removed from the mandrel. In this state the device is now ready for implantation into an intervertebral disc. In use, the encapsulated barrier is folded or crimped via stress-induced martinsite or heat induced martinsite into a delivery cannula so that it may be inserted through a naturally occurring or minimally invasive iatrogenic hole. The unique structure and composition of the device allows it to endure a ninety-degree bend and be delivered parallel to the anular lamellae and in front of the anular defect.
While references are made to a semi-circular frame and matching mandrels, alternative cross sectional shapes of the frame of the present invention may be employed to achieve various stiffness or pressure response characteristics of the overall device. As an example, compound curves may be desirable to create multiple convexities and concavities in the frame. Alternatively, a single concavity with varying radii of curvature may be employed rather than the single radius of a semi-circle. Appropriately shaped mandrels may be used with any of these shapes to achieve the encapsulation methods described above.
Accordingly, utilizing the methods described herein will provide a biocompatible and durable implant. In a preferred embodiment, the implant is folded or crimped into a delivery cannula so that it may be inserted through a naturally occurring or minimally invasive iatrogenic hole. Among other features, the unique structure and composition of the device allows it to endure a ninety-degree bend and to be delivered parallel to the anular lamellae and in front of the anular defect.
While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3867728 *||Apr 5, 1973||Feb 25, 1975||Cutter Lab||Prosthesis for spinal repair|
|US3875595 *||Apr 15, 1974||Apr 8, 1975||Froning Edward C||Intervertebral disc prosthesis and instruments for locating same|
|US4502161 *||Aug 19, 1983||Mar 5, 1985||Wall W H||Prosthetic meniscus for the repair of joints|
|US4665906 *||May 21, 1986||May 19, 1987||Raychem Corporation||Medical devices incorporating sim alloy elements|
|US4798205 *||Oct 23, 1987||Jan 17, 1989||Cox-Uphoff International||Method of using a subperiosteal tissue expander|
|US4821942 *||Jul 11, 1988||Apr 18, 1989||Ophthalmic Ventures Limited Partnership||Driver for surgical microstapler|
|US4890612 *||May 16, 1988||Jan 2, 1990||Kensey Nash Corporation||Device for sealing percutaneous puncture in a vessel|
|US4904260 *||Jul 25, 1988||Feb 27, 1990||Cedar Surgical, Inc.||Prosthetic disc containing therapeutic material|
|US4911718 *||Jun 10, 1988||Mar 27, 1990||University Of Medicine & Dentistry Of N.J.||Functional and biocompatible intervertebral disc spacer|
|US4917704 *||Jun 8, 1988||Apr 17, 1990||Sulzer Brothers Limited||Intervertebral prosthesis|
|US4919667 *||Dec 2, 1988||Apr 24, 1990||Stryker Corporation||Implant|
|US5002576 *||Jun 6, 1989||Mar 26, 1991||Mecron Medizinische Produkte Gmbh||Intervertebral disk endoprosthesis|
|US5100422 *||May 26, 1989||Mar 31, 1992||Impra, Inc.||Blood vessel patch|
|US5108420 *||Feb 1, 1991||Apr 28, 1992||Temple University||Aperture occlusion device|
|US5108438 *||May 7, 1990||Apr 28, 1992||Regen Corporation||Prosthetic intervertebral disc|
|US5176692 *||Dec 9, 1991||Jan 5, 1993||Wilk Peter J||Method and surgical instrument for repairing hernia|
|US5192300 *||Jan 28, 1992||Mar 9, 1993||Quinton Instrument Company||Insertion assembly and method of inserting a vessel plug into the body of a patient|
|US5192301 *||Sep 3, 1991||Mar 9, 1993||Nippon Zeon Co., Ltd.||Closing plug of a defect for medical use and a closing plug device utilizing it|
|US5192326 *||Sep 9, 1991||Mar 9, 1993||Pfizer Hospital Products Group, Inc.||Hydrogel bead intervertebral disc nucleus|
|US5201729 *||Nov 30, 1990||Apr 13, 1993||Laserscope||Method for performing percutaneous diskectomy using a laser|
|US5285827 *||Dec 18, 1992||Feb 15, 1994||Depressurized Technologies International, Inc.||Degassing and decapping apparatus|
|US5292332 *||Jul 27, 1992||Mar 8, 1994||Lee Benjamin I||Methods and device for percutanceous sealing of arterial puncture sites|
|US5306311 *||Dec 17, 1991||Apr 26, 1994||Regen Corporation||Prosthetic articular cartilage|
|US5383905 *||Oct 9, 1992||Jan 24, 1995||United States Surgical Corporation||Suture loop locking device|
|US5397331 *||Nov 25, 1992||Mar 14, 1995||Cook Incorporated||Supporting device and apparatus for inserting the device|
|US5397332 *||Sep 2, 1993||Mar 14, 1995||Ethicon, Inc.||Surgical mesh applicator|
|US5397355 *||Jul 19, 1994||Mar 14, 1995||Stentco, Inc.||Intraluminal stent|
|US5405360 *||Jul 22, 1993||Apr 11, 1995||United States Surgical Corporation||Resilient arm mesh deployer|
|US5500000 *||Jul 1, 1993||Mar 19, 1996||United States Surgical Corporation||Soft tissue repair system and method|
|US5507754 *||Aug 20, 1993||Apr 16, 1996||United States Surgical Corporation||Apparatus and method for applying and adjusting an anchoring device|
|US5591204 *||Oct 5, 1994||Jan 7, 1997||Datascope Investment Corp.||Device and method for sealing puncture wounds|
|US5591223 *||Jun 23, 1994||Jan 7, 1997||Children's Medical Center Corporation||Re-expandable endoprosthesis|
|US5613974 *||Jun 1, 1994||Mar 25, 1997||Perclose, Inc.||Apparatus and method for vascular closure|
|US5620012 *||May 16, 1994||Apr 15, 1997||Benderev; Theodore V.||Method of percutaneously anchoring a suture to a bone|
|US5624463 *||Apr 25, 1994||Apr 29, 1997||Regen Biologics, Inc.||Prosthetic articular cartilage|
|US5705780 *||Jun 2, 1995||Jan 6, 1998||Howmedica Inc.||Dehydration of hydrogels|
|US5716408 *||May 31, 1996||Feb 10, 1998||C.R. Bard, Inc.||Prosthesis for hernia repair and soft tissue reconstruction|
|US5716409 *||Oct 16, 1996||Feb 10, 1998||Debbas; Elie||Reinforcement sheet for use in surgical repair|
|US5716413 *||Oct 11, 1995||Feb 10, 1998||Osteobiologics, Inc.||Moldable, hand-shapable biodegradable implant material|
|US5716416 *||Sep 10, 1996||Feb 10, 1998||Lin; Chih-I||Artificial intervertebral disk and method for implanting the same|
|US5725577 *||Mar 1, 1993||Mar 10, 1998||Saxon; Allen||Prosthesis for the repair of soft tissue defects|
|US5728150 *||Nov 21, 1996||Mar 17, 1998||Cardiovascular Dynamics, Inc.||Expandable microporous prosthesis|
|US5730744 *||Jun 5, 1995||Mar 24, 1998||Justin; Daniel F.||Soft tissue screw, delivery device, and method|
|US5733337 *||Apr 7, 1995||Mar 31, 1998||Organogenesis, Inc.||Tissue repair fabric|
|US5743917 *||Aug 25, 1994||Apr 28, 1998||Saxon; Allen||Prosthesis for the repair of soft tissue defects|
|US5860425 *||Jan 26, 1996||Jan 19, 1999||Boston Scientific Technology, Inc.||Bladder neck suspension procedure|
|US5860977 *||Oct 27, 1997||Jan 19, 1999||Saint Francis Medical Technologies, Llc||Spine distraction implant and method|
|US5865845 *||Mar 5, 1996||Feb 2, 1999||Thalgott; John S.||Prosthetic intervertebral disc|
|US5865846 *||May 15, 1997||Feb 2, 1999||Bryan; Vincent||Human spinal disc prosthesis|
|US5888220 *||Jan 23, 1996||Mar 30, 1999||Advanced Bio Surfaces, Inc.||Articulating joint repair|
|US5888226 *||Nov 12, 1997||Mar 30, 1999||Rogozinski; Chaim||Intervertebral prosthetic disc|
|US5893889 *||Jun 20, 1997||Apr 13, 1999||Harrington; Michael||Artificial disc|
|US6019793 *||Oct 21, 1996||Feb 1, 2000||Synthes||Surgical prosthetic device|
|US6024096 *||May 1, 1998||Feb 15, 2000||Correstore Inc||Anterior segment ventricular restoration apparatus and method|
|US6027527 *||Dec 5, 1997||Feb 22, 2000||Piolax Inc.||Stent|
|US6174311 *||Oct 28, 1998||Jan 16, 2001||Sdgi Holdings, Inc.||Interbody fusion grafts and instrumentation|
|US6179836 *||Oct 28, 1998||Jan 30, 2001||Arthrocare Corporation||Planar ablation probe for electrosurgical cutting and ablation|
|US6183518 *||Mar 23, 1999||Feb 6, 2001||Anthony C. Ross||Method of replacing nucleus pulposus and repairing the intervertebral disk|
|US6187048 *||May 23, 1995||Feb 13, 2001||Surgical Dynamics, Inc.||Intervertebral disc implant|
|US6190353 *||Oct 11, 1996||Feb 20, 2001||Transvascular, Inc.||Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures|
|US6203735 *||Feb 3, 1997||Mar 20, 2001||Impra, Inc.||Method of making expanded polytetrafluoroethylene products|
|US6206921 *||Feb 22, 1999||Mar 27, 2001||Peter A. Guagliano||Method of replacing nucleus pulposus and repairing the intervertebral disk|
|US6214039 *||Aug 24, 1995||Apr 10, 2001||Impra, Inc., A Subsidiary Of C. R. Bard, Inc.||Covered endoluminal stent and method of assembly|
|US6355063 *||Jan 20, 2000||Mar 12, 2002||Impra, Inc.||Expanded PTFE drug delivery graft|
|US6371990 *||Oct 16, 2000||Apr 16, 2002||Bret A. Ferree||Annulus fibrosis augmentation methods and apparatus|
|US6503269 *||Jun 11, 2001||Jan 7, 2003||Scott A. Nield||Method of treating intervertebral discs using optical energy and optical temperature feedback|
|US6508839 *||Oct 25, 2000||Jan 21, 2003||Intrinsic Orthopedics, Inc.||Devices and methods of vertebral disc augmentation|
|US6520967 *||May 15, 2000||Feb 18, 2003||Cauthen Research Group, Inc.||Spinal implant insertion instrument for spinal interbody prostheses|
|US6530932 *||Aug 30, 2000||Mar 11, 2003||Ethicon Endo-Surgery, Inc.||Anastomosis device having improved tissue presentation|
|US6530933 *||Sep 15, 1999||Mar 11, 2003||Teresa T. Yeung||Methods and devices for fastening bulging or herniated intervertebral discs|
|US6712853 *||Dec 17, 2001||Mar 30, 2004||Spineology, Inc.||Annulus-reinforcing band|
|US6719797 *||Aug 14, 2000||Apr 13, 2004||Bret A. Ferree||Nucleus augmentation with in situ formed hydrogels|
|US6726696 *||Jun 28, 2002||Apr 27, 2004||Advanced Catheter Engineering, Inc.||Patches and collars for medical applications and methods of use|
|US6855166 *||Feb 6, 2001||Feb 15, 2005||Zimmer Spine, Inc.||Intevertebral implant with reduced contact area and method|
|US6883520 *||Sep 5, 2002||Apr 26, 2005||Intrinsic Therapeutics, Inc.||Methods and apparatus for dynamically stable spinal implant|
|US7163561 *||May 4, 2004||Jan 16, 2007||Warsaw Orthopedic, Inc.||Flanged interbody spinal fusion implants|
|US7198047 *||May 21, 2003||Apr 3, 2007||Intrinsic Therapeutics, Inc.||Anchored anulus method|
|US20020007218 *||Sep 5, 2001||Jan 17, 2002||Cauthen Joseph C.||Spinal disc annulus reconstruction method and spinal disc annulus stent|
|US20020045942 *||Jul 18, 2001||Apr 18, 2002||Ham Michael J.||Procedure for repairing damaged discs|
|US20020049198 *||Sep 19, 2001||Apr 25, 2002||Littman Bruce H.||Methods for treating osteoarthritis using an estrogen agonist / antagonist|
|US20030004574 *||Aug 22, 2002||Jan 2, 2003||Ferree Bret A.||Disc and annulus augmentation using biologic tissue|
|US20030040796 *||Jun 26, 2002||Feb 27, 2003||Ferree Bret A.||Devices used to treat disc herniation and attachment mechanisms therefore|
|US20030074075 *||Aug 27, 2002||Apr 17, 2003||Thomas James C.||Expandable implant for partial disc replacement and reinforcement of a disc partially removed in a discectomy and for reduction and maintenance of alignment of cancellous bone fractures and methods and apparatuses for same|
|US20030074076 *||Nov 25, 2002||Apr 17, 2003||Ferree Bret A.||Artificial intervertebral disc replacements with endplates|
|US20030078579 *||Oct 3, 2002||Apr 24, 2003||Ferree Bret A.||Annular repair devices and methods|
|US20040002764 *||Apr 30, 2003||Jan 1, 2004||Raymedica, Inc.||Self-transitioning spinal disc anulus occlusion device and method of use|
|US20040010317 *||May 7, 2003||Jan 15, 2004||Gregory Lambrecht||Devices and method for augmenting a vertebral disc|
|US20040024465 *||May 7, 2003||Feb 5, 2004||Gregory Lambrecht||Devices and method for augmenting a vertebral disc|
|US20040030392 *||May 21, 2003||Feb 12, 2004||Lambrecht Greg. H.||Method of supporting nucleus pulposus|
|US20040034429 *||May 21, 2003||Feb 19, 2004||Lambrecht Gregg H,||Anchored anulus method|
|US20040044412 *||May 7, 2003||Mar 4, 2004||Gregory Lambrecht||Devices and method for augmenting a vertebral disc|
|US20050004578 *||Feb 5, 2003||Jan 6, 2005||Lambrecht Gregory H.||Apparatus delivery in an intervertebral disc|
|US20050010205 *||Mar 12, 2004||Jan 13, 2005||Arthrocare Corporation||Methods and apparatus for treating intervertebral discs|
|US20050033440 *||Sep 20, 2004||Feb 10, 2005||Lambrecht Gregory H.||Intervertebral disc implant resistant to migration|
|US20050033441 *||Sep 20, 2004||Feb 10, 2005||Lambrecht Gregory H.||Method of implanting dynamically stable spinal implant|
|US20050038519 *||Sep 20, 2004||Feb 17, 2005||Lambrecht Gregory H.||Method of reducing spinal implant migration|
|US20050060038 *||Sep 20, 2004||Mar 17, 2005||Lambrecht Gregory E.||Flexible implant for intervertebral disc repair|
|US20060030857 *||Aug 6, 2004||Feb 9, 2006||Spinalmotion, Inc.||Methods and apparatus for intervertebral disc prosthesis insertion|
|US20070061012 *||Sep 15, 2006||Mar 15, 2007||Cauthen Joseph C Iii||Intervertebral disc annulus stent|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7658765||Oct 22, 2004||Feb 9, 2010||Intrinsic Therapeutics, Inc.||Resilient intervertebral disc implant|
|US7717961||Feb 5, 2003||May 18, 2010||Intrinsic Therapeutics, Inc.||Apparatus delivery in an intervertebral disc|
|US7727241||Jun 21, 2004||Jun 1, 2010||Intrinsic Therapeutics, Inc.||Device for delivering an implant through an annular defect in an intervertebral disc|
|US7749275||Sep 20, 2004||Jul 6, 2010||Intrinsic Therapeutics, Inc.||Method of reducing spinal implant migration|
|US7867278||Mar 14, 2008||Jan 11, 2011||Intrinsic Therapeutics, Inc.||Intervertebral disc anulus implant|
|US7879097||May 3, 2006||Feb 1, 2011||Intrinsic Therapeutics, Inc.||Method of performing a procedure within a disc|
|US7883527||Oct 31, 2007||Feb 8, 2011||Nuvasive, Inc.||Annulotomy closure device and related methods|
|US7901430||Mar 11, 2005||Mar 8, 2011||Nuvasive, Inc.||Annulotomy closure device and related methods|
|US9039741||Mar 7, 2013||May 26, 2015||Intrinsic Therapeutics, Inc.||Bone anchor systems|
|US20040138673 *||Dec 19, 2003||Jul 15, 2004||Lambrecht Gregory H.||Lateral probe advancement in intervertebral disc tissue|
|US20050004578 *||Feb 5, 2003||Jan 6, 2005||Lambrecht Gregory H.||Apparatus delivery in an intervertebral disc|
|US20050155612 *||Mar 11, 2005||Jul 21, 2005||Nuvasive, Inc.||Annulotomy closure device and related methods|
|US20140088519 *||Sep 26, 2012||Mar 27, 2014||Marshall Kerr||Method and Apparatus Providing Interface Between Subcutaneous Port and Patient Tissue|
|U.S. Classification||264/320, 623/901, 623/17.16|
|International Classification||A61B19/00, A61F2/28, A61F2/02, A61F2/46, A61B17/32, A61F2/00, A61F2/44, A61B17/70, A61F2/30, A61B17/34, A61B5/107, A61B17/00, B29C31/00, A61B17/22|
|Cooperative Classification||A61B2019/461, A61F2310/0097, A61F2002/30172, A61F2002/30131, A61F2220/0075, A61F2002/30576, A61B2017/22077, A61F2002/30136, A61F2002/30583, A61F2310/00976, A61F2310/00029, A61F2002/4662, A61F2002/302, A61F2/2846, A61F2002/30228, A61F2002/30677, A61F2002/30291, A61F2310/00365, A61F2002/448, A61F2002/30601, A61F2002/30589, A61F2230/0013, A61F2002/30289, A61F2210/0004, A61F2/442, A61F2002/30971, A61F2/441, A61F2/30723, A61F2310/00161, A61F2210/0085, A61F2002/30909, A61F2230/0028, A61F2002/30224, A61B2017/00261, A61B2017/3445, A61F2002/30014, A61F2310/00293, A61F2002/30571, A61F2002/30462, A61B5/4514, A61F2310/00023, A61F2002/30261, A61F2002/4661, A61F2230/0069, A61F2002/30187, A61F2002/30566, A61F2002/30166, A61F2/4611, A61F2002/4627, A61F2/4601, A61F2230/0091, A61F2002/2817, A61B5/1076, A61F2002/444, A61F2002/4435, A61F2230/0065, A61F2002/30177, A61F2002/30062, A61F2250/0018, A61F2002/4635, A61F2002/4658, A61F2210/0061, A61F2230/0082, A61F2210/0014, A61F2002/30075, A61F2230/0034, A61F2/30907, A61B2019/462, A61F2002/30092, A61B2017/320044, A61F2230/0004, A61F2230/0056, A61F2002/30785, A61B17/320708, A61F2/4657, A61F2310/00017, A61F2002/30777, A61F2230/0052|
|European Classification||A61F2/44D, A61B5/107J, A61F2/44B, A61F2/46B7, A61F2/46M, A61B17/3207C|